Skip to main content

Research

The latest research in type 1 diabetes, type 2 diabetes, prediabetes, and beyond. Here you’ll find information on experimental therapies, new data and results, and scientific findings.

Discover the hidden risks of diabetic ketoacidosis (DKA) in insulin-treated diabetes. Learn about euglycemic DKA, triggered by SGLT-2 inhibitors.
GLP-1 drugs like Ozempic show promise in addiction treatment, with ongoing research and clinical trials redefining recovery approaches.
Alpha-lipoic acid is an omega-3 fatty acid naturally found in food. Some studies suggest that supplementing with ALA may play a role in treating diabetic neuropathy.
The FDA is investigating reports of suicidal thoughts or actions in people taking diabetes and weight loss medications like Ozempic, Wegovy, and Mounjaro. Research is...
Vertex pauses VX-880 trial after two deaths; fate of diabetes treatment uncertain as current participants continue therapy.
Discover diaTribe's best 2023 diabetes articles on new treatments, advances in technology, lifestyle tips, and groundbreaking insights for better diabetes management.
Over the last few years, the variety of milk products has grown substantially. Cow’s milk, lactose-free milk, almond milk, oat milk – the list goes on. So how do you...
Experts are advocating for universal screening for type 1 diabetes. Early detection can prevent complications like diabetic ketoacidosis. Advances like Tzield can also...
Study shows AI chatbot enhances insulin dosing for type 2 diabetes, improving glycemic control and reducing distress, marking a new era in diabetes management.
Cannabis use in people with type 1 diabetes can raise DKA risk and trigger a condition with similar symptoms called HK-CHS. Monitoring glucose, understanding effects,...
This article details Mounjaro's efficacy in type 2 diabetes management, highlighting the drug’s ability to significantly reduce A1C and body weight. Read about the...
Discover advancements in diabetic macular edema treatment options, including anti-VEGF therapies and non-invasive drugs, for better management of this vision-threatening...
An international consensus was published on World Diabetes Day in the Lancet on bringing an end to diabetes stigma and discrimination. Join the global movement and sign...
Led by Dr. Jeremy Pettus, researchers at UC San Diego are investigating liver-targeted insulin in type 1 diabetes. Explore how this novel insulin could significantly...
Several trials are studying innovative approaches to help people living with diabetes better manage blood glucose levels with CGM, AID systems, and digital health. Here...
People with diabetes are at higher risk for health issues like chronic kidney disease, diabetic macular edema, and liver disease. Here are clinical trials studying ways...
Discover how automated insulin delivery (AID) benefits type 1 diabetes and ongoing trials assessing the impact of AID systems on type 2 diabetes management.
Orforglipron, Eli Lilly's once-daily oral GLP-1 receptor agonist, is being studied in ongoing clinical trials for obesity and type 2 diabetes. Data shows A1C reductions...
Advances in blood glucose management, weight loss, and heart health are at the forefront of type 2 diabetes research. Here are some exciting new clinical trials you can...
The FINE-ONE trial by Bayer investigates Kerendia's effectiveness in preventing kidney disease progression in people with type 1 diabetes. This pivotal trial could...

Pages